Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 90.25 INR
Change Today +0.80 / 0.89%
Volume 6.0K
KBC On Other Exchanges
Symbol
Exchange
Natl India
As of 6:19 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

krebs biochemicals & industr (KBC) Snapshot

Open
88.20
Previous Close
89.45
Day High
94.00
Day Low
88.10
52 Week High
04/17/15 - 149.25
52 Week Low
07/3/14 - 19.70
Market Cap
858.7M
Average Volume 10 Days
5.1K
EPS TTM
-24.62
Shares Outstanding
9.5M
EX-Date
09/14/05
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KREBS BIOCHEMICALS & INDUSTR (KBC)

Related News

No related news articles were found.

krebs biochemicals & industr (KBC) Related Businessweek News

No Related Businessweek News Found

krebs biochemicals & industr (KBC) Details

Krebs Biochemicals & Industries Limited, a biochemical company, manufactures and sells active pharmaceutical ingredients and intermediates in India. It develops biotech processes for application in medicine, agriculture, and industry. The company provides various products for application as anti cholesterols and anti asthmatics. It is also developing an intermediate for Tenofovir anti HIV; and various products for anti cholesterol, cough and cold, and anti obesity therapeutic areas. Krebs Biochemicals & Industries Limited was founded in 1991 and is headquartered in Hyderabad, India.

Founded in 1991

krebs biochemicals & industr (KBC) Top Compensated Officers

Chairman of The Board, Managing Director, Mem...
Total Annual Compensation: 1.5M
Chief Operating Officer, Compliance Officer a...
Total Annual Compensation: 1.4M
Compensation as of Fiscal Year 2014.

krebs biochemicals & industr (KBC) Key Developments

Krebs Biochemicals & Industries Ltd Reports Audited Standalone Earnings Results for the Second Quarter and Six Months Ended March 31, 2015

Krebs Biochemicals & Industries Ltd. reported unaudited standalone earnings results for the second quarter and six months ended March 31, 2015. For the quarter, the company’s loss from operations before other income, finance cost and exceptional items were INR 53.757 million compared to INR 21.830 million a year ago. Loss from ordinary activities before tax was INR 93.905 million compared to INR 21.831 million a year ago. Net loss was INR 64.396 million or INR 6.77 per basic and diluted share compared to INR 21.831 million or INR 2.29 per basic and diluted share for the same period a year ago. For the six months, the company’s loss from operations before other income, finance cost and exceptional items were INR 67.738 million compared to INR 40.388 million a year ago. Loss from ordinary activities before tax was INR 107.911 million compared to INR 39.461 million a year ago. Net loss was INR 78.401 million or INR 8.24 per basic and diluted share compared to INR 43.460 million or INR 4.57 per basic and diluted share for the same period a year ago.

Krebs Biochemicals & Industries Ltd to Report First Half, 2015 Results on May 23, 2015

Krebs Biochemicals & Industries Ltd announced that they will report first half, 2015 results on May 23, 2015

Krebs Biochemicals & Industries Ltd, Board Meeting, May 23, 2015

Krebs Biochemicals & Industries Ltd, Board Meeting, May 23, 2015. Agenda: To consider the audited financial results for the six months period from October 1, 2014 to March 31, 2015; to consider and approve the draft auditors report for the period from October 1, 2014 to March 31, 2015; and to consider any other matter with the permission of the chair.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KBC:IN 90.25 INR +0.80

KBC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KBC.
View Industry Companies
 

Industry Analysis

KBC

Industry Average

Valuation KBC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 5.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KREBS BIOCHEMICALS & INDUSTR, please visit www.krebsbiochem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.